Sign in

Nnennaya Kanu

@nnennayakanu.bsky.social
106 followers 148 following 0 posts

Chief Scientific Officer, CRUK Lung Cancer Centre of Excellence

PostsRepliesMedia
Reposted by Nnennaya Kanu
The Francis Crick Institute @crick.ac.uk · 13/01/2025
Scientists at the Crick, @ucl.ac.uk , @uclh.bsky.social and Personalis have found that a test to detect circulating tumour DNA can help predict the outcome of lung cancer treatments 🧪 First authors: James Black, Gabor Bartha Senior author: @charlesswanton.bsky.social www.crick.ac.uk/news-and-rep...
crick.ac.uk
Tumour DNA in the blood can predict lung cancer outcome
Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumour DNA can predict lung cancer outcome in a Cancer Research UK-funded study.
0377
Reposted by Nnennaya Kanu
Victoria Aranda @vicaranda.bsky.social · 09/01/2025
And lots of cool cancer genomics/genetics this week in Nature too, www.nature.com/articles/s41... 🧪
nature.com
Complex rearrangements fuel ER+ and HER2+ breast tumours - Nature
A study identifies three dominant genomic archetypes of breast cancer induced by discrete mutational processes, describing a continuum of genomic profiles and detailing the mechanisms underlying the p...
072
Reposted by Nnennaya Kanu
Duncan Sproul @sproullab.bsky.social · 09/01/2025
New pre-print alert 🚨 Interested in what @ikafetzo.bsky.social learned about DNA hypomethylation in cancer from investigating surprising gains DNA methylation in DNMT1 KO cells? Read all about it here: www.biorxiv.org/content/10.1... For a quick summary see this 🧵 1/8 #epigenetics
biorxiv.org
DNMT1 loss leads to hypermethylation of a subset of late replicating domains by DNMT3A
Loss of DNA methylation is a hallmark of cancer that is proposed to promote carcinogenesis through gene expression alterations, retrotransposon activation and induction of genomic instability. Cancer-...
3459
Reposted by Nnennaya Kanu
Wei-Ting Lu @weitinglu.bsky.social · 03/01/2025
We hope this is useful for the field. Our paper can be found here: www.nature.com/articles/s41... Or the readcube link below: rdcu.be/d5gAe Finally we wish everyone a happy new year!!! 14/end
nature.com
TRACERx analysis identifies a role for FAT1 in regulating chromosomal instability and whole-genome doubling via Hippo signalling - Nature Cell Biology
Lu et al. perform systematic functional analyses using data from the TRACERx cohort of patients with non-small-cell lung cancer and delineate how FAT1 regulates homologous recombination repair, chromo...
021
Reposted by Nnennaya Kanu
Wei-Ting Lu @weitinglu.bsky.social · 03/01/2025
Finally, a huge thank you to all our funders without which our work would not be possible @crick.ac.uk, Genomics England, @cancerresearchuk.org, @uclh.bsky.social @bcrfcure.bsky.social, Danish Cancer Society, UCL Cancer Institute and @cruk-cityoflondon.bsky.social. 13/14
121
Reposted by Nnennaya Kanu
Wei-Ting Lu @weitinglu.bsky.social · 03/01/2025
I am happy to see that our paper is out just before the new year!!! We have a lab tweetorial out for anyone interested! Got to say it was an exciting journey working with CharlesSwanton, the wider TRACERx and PEACE team, and @nnennayakanu.bsky.social Jiri Bartek labs. 🧵1/14
1114
Reposted by Nnennaya Kanu
Chris Lord and Andrew Tutt’s Lab Institute of Cancer Research @icrlordlab.bsky.social · 27/12/2024
www.icr.ac.uk/about-us/icr...
icr.ac.uk
New understanding of aggressive form of breast cancer paves the way for tests and treatments
Scientists have developed a machine learning tool that can predict how an aggressive type of breast cancer will respond to treatment, and when it will return.
041